InsidersTradesSigma
Follow the 科研製薬株式会社 stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares trade on JP JP, under the oversight of EDINET (Japan FSA). Market capitalisation: €143.9bn. The latest transaction was filed on 26 November 2024 (Holding update). Among the most active insiders: ―. The full history is openly available.
Analysts rate 科研製薬株式会社 Hold (neutral), based on 4 analysts. Average price target: JP¥4,350.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Kaken Pharmaceutical Co., Ltd. is a Japanese company focused on the research and development of pharmaceutical products. It is listed on the XTKS market.